Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
The Medical Clinics of North America|October 24, 2021
Evolving Concepts of Type 2 Diabetes ManagementLayla A Abushamat, Jane E B ReuschJournal of the Endocrine Society|July 16, 2020
Mechanistic Causes of Reduced Cardiorespiratory Fitness in Type 2 DiabetesLayla A Abushamat, P Mason McClatchey, Rebecca L Scalzo, et al.The American Journal of Cardiology|September 17, 2002
Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndromeJane E B ReuschThe Journal of Clinical Investigation|October 3, 2003
Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?Jane E B ReuschCurrent Cardiology Reports|July 20, 2024
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?Jennifer M Kaplan, Adnin Zaman, Layla A AbushamatDiabetes Technology & Therapeutics|September 27, 2003
Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetesJane E-B Reusch, Roger GadsbyCurrent Diabetes Reports|February 22, 2011
Cardiovascular function/dysfunction in adolescents with type 1 diabetesKristen J Nadeau, Jane E B ReuschThe Journal of Biological Chemistry|November 6, 2001
Inhibition of cAMP-response element-binding protein activity decreases protein kinase B/Akt expression in 3T3-L1 adipocytes and induces apoptosisJane E B Reusch, Dwight J KlemmDiabetes, Obesity & Metabolism|June 26, 2007
Atherosclerosis in diabetes and insulin resistanceJane E-B Reusch, Boris B DrazninJournal of the American College of Cardiology|April 15, 2022
Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7Judith G Regensteiner, Jane E B ReuschPageof 14